NRSN•benzinga•
NeuroSense Therapeutics Signs Binding Term Sheet With Global Pharma Partner To Advance PrimeC For ALS; Includes Upfront Payment, Phase 3 Funding, Milestone Payments, And Double-Digit Royalties; Definitive Agreement Expected Q1 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 23, 2024 by benzinga